A Centers for Medicare & Medicaid Services (CMS) proposal would cut providers' reimbursement for dialysis treatment by 9.4%, or approximately $1 billion, nationwide.
A Centers for Medicare & Medicaid Services (CMS) proposal would cut providers’ reimbursement for dialysis treatment by 9.4%, or approximately $1 billion, nationwide. Such changes alarm providers in the aftermath of other funding reductions that have affected Medicare, including the government sequestrian, and other mandates associated with health reform. The recommendations are part of adjustments to the end-stage renal disease (ESRD) program.
“This is a very dramatic cut," Robert Sepucha, Senior VP, Policy and Business Development at Fresenius Medical Care, said. “We’re concerned it would push dialysis clinics under the cost of care, which is not the right thing for Medicare to be doing.”
Recent estimates show that 85% of American dialysis patients rely on Medicare to receive kidney disease treatment. The CMS cuts would affect almost half a million Americans, threating the quality of care for some of the most sickly and vulnerable patients. An additional 20 million of those affected are at increased risk of ESRD due to health and genetic factors and may require dialysis in the future.
Heather Dauler, Director of Government Affairs at Satellite Healthcare, said communities rely on providers like the Satellite clinic to provide high quality care in an accessible way. “While we will continue to strive to meet these needs, the extent of the proposed cuts may compromise our ability to do so,” Ms Dauler commented.
Medicare had already faced difficulties in covering costs for many ESRD patients, even before the sequestrian effects.
"Dialysis providers are struggling to absorb and adjust to the other Medicare cuts made to the program in recent years," said Ron Kuerbitz, Chair of Kidney Care Partners. "The current proposal is untenable, and would dramatically underfund this crucial therapy for Medicare beneficiaries on dialysis. To protect the well-being of our patients, CMS must ensure that Medicare reimbursement is adequate to cover the cost of providing quality care.”
The CMS proposal remains open to public comment until August 30.
Around the Web
DaVita Among Dialysis Outlets Facing 9.4% Medicare Cut [Bloomberg]
Proposed Medicare Cuts Have Broad Implications For Dialysis Services Offerings [Herald Online]
Nation's Kidney Community Deeply Concerned Over Government's "Untenable" Proposed Cut to the Nation's Medicare's Dialysis Program
What We’re Reading: RSV Vaccine Demand; Permanent Contraception; Drug Negotiation Impact
December 8th 2023The Biden administration recently met with manufacturers of respiratory syncytial virus (RSV) immunizations to encourage them to increase access to the vaccine; since the Dobbs v Jackson decision, many patients have been seeking more permanent reproductive health care solutions; a Mathematica analysis showed that Medicare prescription drug price negotiations could have cut seniors’ out-of-pocket costs by nearly a quarter had the program been in effect in 2021.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Data analysis showed that 40% of patients who filled a prescription for Wegovy in 2021 or 2022 were still taking it a year later; both Democrats and reproductive rights organizations are pressuring the Biden administration to ensure health insurers fully cover contraception; CMS implemented Medicare changes in March that limited access to blood tests that help transplant recipients ensure their organs remain healthy.
Read More
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen